PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
04-May-2022 NanoVibronix Announces FDA 510(k) Submission for PainShield® MD PLUS Businesswire
04-May-2022 Aldeyra Therapeutics to Present at MOD Live! 2022 Meeting Businesswire
04-May-2022 $950+ Mn Pick To Light Markets - Global Forecasts from 2022 to 2027 - ResearchAndMarkets.com Businesswire
04-May-2022 Global Nanopatterning Market Trajectory & Analytics Report 2022: Breakdown by UV Nanoimprint Lithography, Hot Embossing Lithography, and Other Technologies - ResearchAndMarkets.com Businesswire
04-May-2022 Phesi global analysis of 2.5 million patients finds participants in breast cancer clinical trials are getting younger Phesi
04-May-2022 Amphera’s MesoPher Cell Therapy Demonstrates Favourable Safety and Promising Survival in a Phase II Clinical Trial in Resected Pancreatic Cancer Businesswire
04-May-2022 Melt Pharmaceuticals Announces MELT-210 Top-Line Results of Phase 1 Pharmacokinetics (PK) Study for Procedural Sedation Businesswire
04-May-2022 New Cation Trap Column Workflow Improves Uptime for Anionic Contaminants Testing of Industrial Waters Businesswire
04-May-2022 Julianne Averill and Kristen Richardson Join Anji Pharma to Ready Company for Next Stage of Growth Businesswire
04-May-2022 OliX Pharmaceuticals Identifies Effective Inhibition of Target Gene Expression and Delivery of Candidate to Brain for CNS Therapeutics Businesswire
04-May-2022 NextGen Healthcare Partners with Circuit Clinical to Bolster Diversity in Clinical Trials by Extending Access to Underserved Communities Businesswire
04-May-2022 Almirall Deploys Aktana's Contextual Intelligence 360 to Optimize Customer Engagement Businesswire
04-May-2022 The Worldwide Opioids Industry is Expected to Reach $6 Billion by 2030 - ResearchAndMarkets.com Businesswire
04-May-2022 Insights on the Cognitive and Memory Enhancer Drugs Global Market to 2030 - High Incidence of Neurodegenerative Disorders is Driving Growth - ResearchAndMarkets.com Businesswire
04-May-2022 New Data Opens Potential for Patient Stratification for CriPec® Nanomedicines in Cancer and Other Indications via Non-Invasive Imaging Cristal Therapeutics
04-May-2022 New Data Opens Potential for Patient Stratification for CriPec® Nanomedicines in Cancer and Other Indications via Non-Invasive Imaging Cristal Therapeutics
04-May-2022 Global Testing, Inspection, and Certification Market Analysis/Forecast Report 2022-2027 - ResearchAndMarkets.com Businesswire
04-May-2022 ADC Therapeutics to Present at the BofA Securities 2022 Healthcare Conference Businesswire
04-May-2022 Horizon Therapeutics plc Reports First-Quarter 2022 Financial Results Businesswire
04-May-2022 Charles River Laboratories Announces First-Quarter 2022 Results Businesswire